Abstract
Flora in ICUs has changed with the development of new therapies and the implementation of protocols regarding bacterial infections. As a result, this could increase our concerns about fungal infections and modify the indications and the way we use them.
Highlights
Flora in ICUs has changed with the development of new therapies and the implementation of protocols regarding bacterial infections
2417 patients were treated with antifungal drugs (AD). 400 received more than one AD and 72 of them more than 2
Of 1481 cases where the AD is started empirically, the adequacy is confirmed in 21.3%; in 45.0% of the cases the cultures were negative or were not collected; in 15.8% the infection is not confirmed
Summary
To assess the indications for the use of antifungal drugs (AD) during the 2013-2014 period using data from the ENVIN-HELICS registry
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
